ArticleThe Lancet regional health. Europe2025
Fertility, time to pregnancy, and pregnancy outcomes among women with recurrent miscarriages in the UK: a prospective observational longitudinal study.
Article in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spleen-associated macrophage alterations and embryo viability in a murine model of recurrent spontaneous abortion.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Article
- Can predicting future pregnancies after loss personalise miscarriage care?The Lancet regional health. Europe · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recurrent miscarriage is a debilitating disorder associated with considerable physical and psychological morbidity. An estimated 50% of first trimester miscarriages remain unexplained. The aim of this study was to provide a personalised framework to guide the expectations of women experiencing recurrent miscarriage, with the ultimate goal of transforming clinical practice. Methods: We used real-world data from a UK longitudinal study of 1201 couples attending National Health Service (NHS) miscarriage clinics, with a history of previous miscarriages, comprising medical and obstetric history, results of investigations and pregnancy and neonatal outcome. We developed, parametrised, and validated predictive models for the probability that the next pregnancy is viable and for the time to next pregnancy. Time to next pregnancy separates couples into two groups, a group with subfertility, Findings: Predictive models of the time to pregnancy, the probability of the couple being subfertility and the probability of having a viable pregnancy can be parametrised from longitudinal study data. We identified several predictors for such models. In the viable pregnancy model, increased maternal age, higher Body Mass Index (BMI), having Polycystic Ovaries Syndrome (PCOS) and the number of previous miscarriages were associated with reduced odds of viable pregnancy. In contrast, having had previous live births increased the odds of a viable pregnancy. Model validation against a second external dataset gave an Area Under Curve (AUC) of 0.65 (95% Confidence Interval (CI): 0.55, 0.76). Of the 942 women referred to our recurrent miscarriage clinics and followed up over a period of 3 years, 10.7% (101) did not conceive during this time, indicating a potential subfertility problem. In the time to pregnancy model, increased maternal age, higher BMI, and smoking were associated with reduced likelihood of conception. Conversely, taking folic acid supplements and having a history of previous conceptions were associated with increased fertility. In our cohort, 53.4% (577 out of 1080 women) reported a pregnancy within 12 months. Additionally, 22.8% (277 out of 996 women who were followed up over a 2-year period) experienced a first pregnancy event in the second year. The area under the curve (AUC) for predicting pregnancy within 12 months was 0.60 (95% CI: 0.50-0.70) in an external validation using a second dataset. Interpretation: The pregnancy journey can be predicted on a personalised basis by integrating the validated models. We provide a framework for evidence-based management of women with miscarriage, comprising informed decision-making, including optimal referral to fertility services, and a tailored insight into fertility outcomes, thereby guiding expectations and providing psychological support. Funding: Tommy's National Centre for Miscarriage Research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.